Pulmonx Corporation Stock Analysis & AI Score
Pulmonx Corporation (LUNG) has an ST Score of 51.9 (C+), driven by its Forecast (A) and held back by its Profitability (D). Analysts rate it Buy with a $10.00 price target (+426.3% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Pulmonx Corporation (LUNG) has an ST Score of 51.9 (C+), driven by its Forecast (A) and held back by its Profitability (D). Analysts rate it Buy with a $10.00 price target (+426.3% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityD
All factor grades
- ForecastA
- ValuationA-
- MomentumB+
- GrowthC+
- Financial StrengthC-
- ProfitabilityD
- Piotroski3/9
Contact
LUNG stock: frequently asked questions
What is LUNG's ST Score?
Pulmonx Corporation (LUNG) has an ST Score of 51.9 (C+), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LUNG a buy, hold, or sell?
Analysts rate LUNG a Buy, with a price target of $10.00 (+426.3% vs the current price). Our ST Score grades it C+ (51.9/100). The ST Score is a data-driven signal, not a recommendation.
What are LUNG's factor grades?
Valuation A-, Profitability D, Financial Strength C-, Momentum B+, Growth C+, Forecast A.
What is LUNG's valuation grade?
Pulmonx Corporation (LUNG) earns a valuation grade of A-, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LUNG's growth grade?
Pulmonx Corporation (LUNG) earns a growth grade of C+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LUNG's profitability grade?
Pulmonx Corporation (LUNG) earns a profitability grade of D, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LUNG's financial strength grade?
Pulmonx Corporation (LUNG) earns a financial strength grade of C-, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LUNG?
The average analyst price target for Pulmonx Corporation (LUNG) is $10.00 from 9 analysts, which is +426.3% versus the recent price of $1.90.
What is LUNG's Piotroski score?
Pulmonx Corporation (LUNG) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.